TPC
Takeda Pharmaceutical Company Portfolio holdings
AUM
$19.6M
This Quarter Return
-3.47%
1 Year Return
-13.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$232M
AUM Growth
+$232M
(-20%)
Cap. Flow
-$22.5M
Cap. Flow
% of AUM
-9.7%
Top 10 Holdings %
Top 10 Hldgs %
99.63%
Holding
15
New
–
Increased
–
Reduced
3
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Phathom Pharmaceuticals
PHAT
|
$16.4M |
| 2 |
Shattuck Labs
STTK
|
$3.8M |
| 3 |
Day One Biopharmaceuticals
DAWN
|
$1.42M |
| 4 |
Rani Therapeutics
RANI
|
$469K |
| 5 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$402K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Denali Therapeutics
DNLI
$2.23B
| $97.9M | 42.13% | 4,214,559 | – | – |
|
2
HilleVax
HLVX
$105M
| $97.2M | 41.85% | 6,724,000 | – | – |
|
|
3
Phathom Pharmaceuticals
PHAT
$864M
| $16M | 6.9% | 1,557,063 -1,596,154 | -51% | -$16.4M |
|
4
Wave Life Sciences
WVE
$1.53B
| $6.72M | 2.89% | 1,346,892 | – | – |
|
5
Ovid Therapeutics
OVID
$91M
| $5.79M | 2.49% | 7,531,996 | – | – |
|
|
TSBX
6
DELISTED
Turnstone Biologics
TSBX
| $2.35M | 1.01% | 895,824 | – | – |
|
|
7
Shattuck Labs
STTK
$47M
| $1.99M | 0.86% | 515,619 -985,442 | -66% | -$3.8M |
|
8
Xilio Therapeutics
XLO
$36.3M
| $1.4M | 0.6% | 1,475,121 | – | – |
|
9
Equillium
EQ
$62.2M
| $1.26M | 0.54% | 1,824,977 | – | – |
|
|
10
Rani Therapeutics
RANI
$24.4M
| $818K | 0.35% | 215,172 -123,507 | -36% | -$469K |
|
11
American Well
AMWL
$111M
| $505K | 0.22% | 1,554,669 | – | – |
|
|
AKLI
12
DELISTED
Akili, Inc. Common Stock
AKLI
| $321K | 0.14% | 738,819 | – | – |
|
13
Standard BioTools
LAB
$481M
| $29.2K | 0.01% | 16,515 | – | – |
|
|
JBIO
14
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – | -13,580 | Closed | -$402K |
|
|
15
Day One Biopharmaceuticals
DAWN
$769M
| – | – | -85,840 | Closed | -$1.42M |
|